- Investing Ideas
- /
- Swiss Potentially Undervalued Companies
Swiss Potentially Undervalued Companies
UPDATED May 02, 2024
Companies with a Value score of at least 3, ordered by Value score
371 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
BARC | UK£1.71 | 0% | 0% | UK£30.1b | UK£2.10 | PB0.4x | E11.4% | 4.0% | Banks | ||
CONT | €144.60 | 0% | 0% | €12.2b | €197.16 | PE10.6x | E18.8% | 3.6% | Automobiles | ||
CWC | €92.60 | 0% | 0% | €694.3m | €124.02 | PE11.6x | E3.3% | 2.6% | Commercial Services | ||
POM | €34.90 | 0% | 0% | €1.6b | €42.90 | PE10.1x | E18.1% | 3.4% | Automobiles | ||
VETN | CHF30.85 | -0.6% | -32.2% | CHF611.6m | CHF45.33 | PE9.7x | E12.0% | 3.2% | Materials | ||
ADEN | CHF31.78 | 2.1% | 10.7% | CHF5.3b | CHF38.67 | PE16.8x | E22.8% | 7.8% | Commercial Services | ||
BIIB | US$222.00 | 0% | 0% | US$31.5b | US$297.19 | PE26.6x | E17.8% | n/a | Pharmaceuticals & Biotech | ||
MOZN | CHF13.16 | 0.3% | -3.1% | CHF567.7m | CHF16.70 | PE11.5x | E5.8% | 3.8% | Retail | ||
ASCN | CHF7.55 | 2.4% | -13.2% | CHF271.2m | CHF12.17 | PE15.6x | E12.9% | 4.0% | Healthcare | ||
BOSS | €80.00 | 0% | 0% | €3.2b | €119.23 | PE12.6x | E13.8% | 2.9% | Consumer Durables | ||
DBAN | €33.50 | 0% | 0% | €516.8m | €52.89 | PE8.9x | E25.0% | 3.6% | Diversified Financials | ||
JEN | €37.10 | 0% | 0% | €1.4b | €51.93 | PE19.8x | E15.9% | 1.4% | Tech | ||
ZEHNE | CHF54.60 | -1.3% | 5.6% | CHF603.2m | CHF80.77 | PE11.6x | E6.7% | 3.3% | Capital Goods | ||
BABA | US$160.00 | 0% | -2.4% | US$176.3b | US$236.12 | PE12.7x | E11.1% | 1.4% | Retail | ||
24409862 | US$160.00 | 0% | n/a | US$183.8b | US$222.39 | PE13.3x | E10.6% | 1.3% | Retail | ||
4MGN | US$28.91 | -9.6% | n/a | US$8.3b | US$40.87 | PE12.7x | E7.8% | n/a | Media | ||
J7Z | US$104.98 | 0% | n/a | US$6.9b | US$175.41 | PE20.8x | E16.8% | n/a | Pharmaceuticals & Biotech | ||
MER | €147.03 | 0% | n/a | €64.8b | €179.65 | PE22.9x | E10.1% | 1.5% | Pharmaceuticals & Biotech | ||
UBSGE | CHF19.44 | 0% | 0% | CHF77.9b | CHF22.47 | PE3.1x | E-34.0% | 2.6% | Diversified Financials | ||
EFGN | CHF11.26 | 5.4% | 36.7% | CHF3.4b | CHF12.61 | PE11.9x | E3.8% | 4.9% | Diversified Financials | ||
MO | US$47.20 | 0% | -2.1% | US$75.3b | US$50.28 | PE8.9x | E2.5% | 8.9% | Food, Beverage & Tobacco | ||
SREN | CHF99.20 | -0.3% | 12.8% | CHF28.8b | CHF110.75 | PE9.8x | E7.5% | 6.2% | Insurance | ||
CAT | US$308.00 | -1.3% | 33.9% | US$161.9b | US$306.87 | PE14.6x | E-2.8% | 1.6% | Capital Goods | ||
UBSG | CHF24.29 | -2.7% | 45.1% | CHF77.9b | CHF28.06 | PE3.1x | E-34.0% | 2.6% | Diversified Financials |